Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
Company Reports $3.0 Million in Net Product Revenues from COPIKTRA®; Raises Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
Pharmaceuticals, Biotechnology and Life Sciences
Company Reports $3.0 Million in Net Product Revenues from COPIKTRA®; Raises Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune…
SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health Solutions, Inc., a pioneer in advanced healthcare analytics and care optimization, is pleased to announce that…
Respected scientific expert and motivator recognized for dedication to bringing clinical trials to life in rare and orphan diseases RESEARCH…
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Therapeutics/Drug Market Analysis By Class (Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, Anti-glaucoma), By Disease (Dry Eye, Allergies, Glaucoma, Infection,…
DUBLIN–(BUSINESS WIRE)–The “Hemophilia Market Analysis By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Treatment (On-demand, Prophylaxis), By Therapy (Replacement…
Noted Physician-Scientist Brings Far-Reaching Expertise CAMBRIDGE, Mass.–(BUSINESS WIRE)–Glympse Bio, Inc., a life science company developing in vivo activity sensors to…
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the availability of an expanded access program for its investigational medicine teprotumumab.…
NEW YORK–(BUSINESS WIRE)–#analytics–PharmaVOICE has named Asaf Evenhaim, the CEO and co-founder of Crossix, as one of its PharmaVOICE 100 for…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug…